Concepedia

The results of SGLT-2 inhibitors use in kidney transplantation: 1-year experiences from two centers

Mehmet Emin Demir, Tuba Elif Özler, Özgür Merhametsiz, Ulaş Sözener, Murathan Uyar, Zafer Ercan, Simge Bardak, Siren Sezer, Gülçin Türkmen Sarıyıldız

International Urology and Nephrology · 2023 · 17 citations · 16 references

DOIFull text

Open access

Concepts

References

16

Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy

Vlado Perkovic, Meg Jardine, Bruce Neal et al. · New England Journal of Medicine · 2019 · 6K citations · Full text

, , +17

Dapagliflozin in Patients with Chronic Kidney Disease

Hiddo J.L. Heerspink, Bergur V. Stefánsson, Ricardo Correa‐Rotter et al. · New England Journal of Medicine · 2020 · 5.2K citations · Full text

, , +16

2. Classification and Diagnosis of Diabetes:<i>Standards of Medical Care in Diabetes—2022</i>

Diabetes Care · 2021 · 4.7K citations · Full text

, , +11

Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes

Christoph Wanner, Silvio E. Inzucchi, John M. Lachin et al. · New England Journal of Medicine · 2016 · 3.6K citations · Full text

, , +17

Canagliflozin and renal outcomes in type 2 diabetes: results from the CANVAS Program randomised clinical trials

Vlado Perkovic, Dick de Zeeuw, Kenneth W. Mahaffey et al. · The Lancet Diabetes & Endocrinology · 2018 · 643 citations · Full text

, , +16